IndraLab

Statements


| 5

reach
"MYSM1 deletion activated NF-κB and MAPK signaling, significantly promoting OA development and exacerbating cartilage degeneration."

reach
"MYSM1 attenuates NF-kappaB and MAPK signaling pathways in chondrocytes."

reach
"These results indicate that MYSM1 deactivates NF-κB and MAPK signaling pathways, thereby protecting mouse chondrocytes against inflammation."

reach
"Mechanistically, MYSM1 inhibited the NF-kappaB and MAPK signaling pathways."

reach
"Our findings demonstrate that Mysm1 overexpression deactivates NF-κB and MAPK signaling pathways, whereas Mysm1 knockdown significantly activates these pathways in mouse chondrocytes."